Omaha, NE, United States of America

Yuangqing Tang


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Yuangqing Tang

Introduction

Yuangqing Tang is a notable inventor based in Omaha, NE (US). He has made significant contributions to the field of medicine, particularly in the development of antimalarial treatments. His work focuses on creating effective and non-toxic compounds that can combat serious diseases.

Latest Patents

Yuangqing Tang holds a patent for "Spiro and dispiro 1,2,4-trioxolane antimalarials." This invention describes a means and method for treating malaria, schistosomiasis, and cancer using a spiro or dispiro 1,2,4-trioxolane. The preferred compounds include a spiroadamantane group on one side of the trioxolane group and a spirocyclohexyl on the other side, with the spirocyclohexyl ring preferably substituted at the 4-position. Compared to artemisinin semisynthetic derivatives, the compounds of this invention are structurally simple, easy to synthesize, non-toxic, and potent against malarial parasites. He has 1 patent to his name.

Career Highlights

Yuangqing Tang is associated with Medicines for Malaria Venture (MMV), where he continues to work on innovative solutions for malaria treatment. His research has the potential to significantly impact public health by providing more effective and safer treatment options.

Collaborations

Some of his notable coworkers include Jonathan L. Vennerstrom and Yuxiang Dong. Their collaborative efforts contribute to the advancement of research in antimalarial therapies.

Conclusion

Yuangqing Tang's innovative work in developing antimalarial compounds showcases his commitment to improving health outcomes. His contributions are vital in the ongoing fight against malaria and other serious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…